Moreover, when compared to healthy donors (HD), MS patients showed lower percentages in Ag-specific cells able to produce IFN-γ, interleukin (IL)−2 and tumor necrosis factor (TNF)34. This evidence concerns the gene IL2 and myeloid sarcoma.